PLRZ
NASDAQ
$13.26
Polyrizon Ltd (PLRZ)
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company is headquartered in Ra'anana, Israel.
Sector:
Healthcare
Industry:
Biotechnology
Market Cap
$21M
Free Cash Flow Yield
-21.57%
Beta (5Y)
0.41
Price Chart
Valuation
Market Cap$21M
P/B1.34
Profitability
EBITDA-$5.91M
EPS-$2.07
Financial Health
Free Cash Flow Yield-21.57%
Growth & Risk
Beta (5Y)0.41
Sharpe Ratio1.12